昊海生科(688366.SH)拟购买瑞济生物19.8%股权

智通财经2025-12-12

智通财经APP讯，昊海生科(688366.SH)发布公告，公司拟以自有资金人民币3835.15万元受让苗九昌、苗春云合计持有的江西瑞济生物工程技术股份有限公司(以下简称“瑞济生物”)846.61万股股份，占瑞济生物总股本的19.8%。瑞济生物于2002年成立，主营业务是生产、销售生物羊膜。主要产品和服务为凹凸羊膜产品、生物骨科羊膜产品、湿态生物羊膜产品，属国家三类医疗器械，主要用于骨科和眼科领域，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2590097485?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-12-12 21:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2590097485","market":"fut","top_or_hot":-1,"title":"昊海生科(688366.SH)拟购买瑞济生物19.8%股权","media":"智通财经","content":"<div>\n<p>智通财经APP讯，昊海生科(688366.SH)发布公告，公司拟以自有资金人民币3835.15万元受让苗九昌、苗春云合计持有的江西瑞济生物工程技术股份有限公司(以下简称“瑞济生物”)846.61万股股份，占瑞济生物总股本的19.8%。瑞济生物于2002年成立，主营业务是生产、销售生物羊膜。主要产品和服务为凹凸羊膜产品、生物骨科羊膜产品、湿态生物羊膜产品，属国家三类医疗器械，主要用于骨科和眼科领域，...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1381152.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>昊海生科(688366.SH)拟购买瑞济生物19.8%股权</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n昊海生科(688366.SH)拟购买瑞济生物19.8%股权\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-12 21:16 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1381152.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，昊海生科(688366.SH)发布公告，公司拟以自有资金人民币3835.15万元受让苗九昌、苗春云合计持有的江西瑞济生物工程技术股份有限公司(以下简称“瑞济生物”)846.61万股股份，占瑞济生物总股本的19.8%。瑞济生物于2002年成立，主营业务是生产、销售生物羊膜。主要产品和服务为凹凸羊膜产品、生物骨科羊膜产品、湿态生物羊膜产品，属国家三类医疗器械，主要用于骨科和眼科领域，...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1381152.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0251","symbol_name":"专用设备","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1381152.html","article_id":"2590097485","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2590097485","pubTimestamp":1765545414,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，昊海生科 发布公告，公司拟以自有资金人民币3835.15万元受让苗九昌、苗春云合计持有的江西瑞济生物工程技术股份有限公司846.61万股股份，占瑞济生物总股本的19.8%。瑞济生物于2002年成立，主营业务是生产、销售生物羊膜。主要产品和服务为凹凸羊膜产品、生物骨科羊膜产品、湿态生物羊膜产品，属国家三类医疗器械，主要用于骨科和眼科领域，包括肌腱损伤后的修复、眼表烧伤创伤及损害创面的修复、泪道阻塞探通后的植入和支撑等。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688366":"昊海生科","BK0251":"专用设备","BK0239":"医药制造"},"translate_title":"Haohai Biotech (688366. SH) plans to purchase 19.8% equity of Ruiji Biotech","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688366":1.5},"content_text":"智通财经APP讯，昊海生科(688366.SH)发布公告，公司拟以自有资金人民币3835.15万元受让苗九昌、苗春云合计持有的江西瑞济生物工程技术股份有限公司(以下简称“瑞济生物”)846.61万股股份，占瑞济生物总股本的19.8%。瑞济生物于2002年成立，主营业务是生产、销售生物羊膜。主要产品和服务为凹凸羊膜产品、生物骨科羊膜产品、湿态生物羊膜产品，属国家三类医疗器械，主要用于骨科和眼科领域，包括肌腱损伤后的修复、眼表烧伤创伤及损害创面的修复、泪道阻塞探通后的植入和支撑等。公司通过投资标的公司，并获取标的公司产品在中国境内经销权，切入生物羊膜这一高价值医疗器械赛道，有效补充公司现有的产品组合，拓展眼科与骨科领域的业务覆盖。与此同时，标的公司所掌握的羊膜材料具备人源性生物学特性，为公司相关业务在再生医学与组织工程领域的研究与发展提供重要的技术及材料基础，有望推动后续产品创新与技术升级。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2590097485","isCrawlerRequest":true}